75000 - Document - Cover
link:presentationLink
link:calculationLink
link:definitionLink
75010 - Statement - Condensed Consolidated Balance Sheets
link:presentationLink
link:calculationLink
link:definitionLink
75020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
75030 - Statement - Condensed Consolidated Statements of Operations
link:presentationLink
link:calculationLink
link:definitionLink
75040 - Statement - Consolidated Statements of Comprehensive Loss
link:presentationLink
link:calculationLink
link:definitionLink
75050 - Statement - Consolidated Statements of Changes in Shareholders' Equity
link:presentationLink
link:calculationLink
link:definitionLink
75060 - Statement - Consolidated Statements of Cash Flows
link:presentationLink
link:calculationLink
link:definitionLink
995455 - Disclosure - Organization, Basis of Presentation and Liquidity
link:presentationLink
link:calculationLink
link:definitionLink
995465 - Disclosure - Summary of Significant Accounting Policies
link:presentationLink
link:calculationLink
link:definitionLink
995475 - Disclosure - Revenue
link:presentationLink
link:calculationLink
link:definitionLink
995495 - Disclosure - Property and Equipment, Net
link:presentationLink
link:calculationLink
link:definitionLink
995505 - Disclosure - Goodwill and Intangible Assets, Net
link:presentationLink
link:calculationLink
link:definitionLink
995515 - Disclosure - Accounts Payable and Accrued Liabilities
link:presentationLink
link:calculationLink
link:definitionLink
995525 - Disclosure - Fair Value Measurements
link:presentationLink
link:calculationLink
link:definitionLink
995535 - Disclosure - Related Party Transactions
link:presentationLink
link:calculationLink
link:definitionLink
995545 - Disclosure - Shareholders' Equity
link:presentationLink
link:calculationLink
link:definitionLink
995555 - Disclosure - Stock-Based Awards
link:presentationLink
link:calculationLink
link:definitionLink
995565 - Disclosure - Income Taxes
link:presentationLink
link:calculationLink
link:definitionLink
995575 - Disclosure - Commitments and Contingencies
link:presentationLink
link:calculationLink
link:definitionLink
995585 - Disclosure - Summary of Significant Accounting Policies (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
995595 - Disclosure - Organization, Basis of Presentation and Liquidity (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995605 - Disclosure - Revenue (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995625 - Disclosure - Property and Equipment, Net (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995635 - Disclosure - Goodwill and Intangible Assets, Net (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995645 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995655 - Disclosure - Fair Value Measurements (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995665 - Disclosure - Shareholders' Equity (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995675 - Disclosure - Stock-Based Awards (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995685 - Disclosure - Commitments and Contingencies (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995695 - Disclosure - Organization, Basis of Presentation and Liquidity - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995705 - Disclosure - Organization, Basis of Presentation and Liquidity - Schedule of Lineage's Ownership of Outstanding Shares of its Subsidiaries (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995715 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995725 - Disclosure - Revenue - Schedule of Disaggregated Revenues (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995735 - Disclosure - Revenue - Schedule of Disaggregated Revenues (Parenthetical) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995745 - Disclosure - Revenue - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995755 - Disclosure - Revenue - Schedule of Contract with Customer Contract Liability and Receivable (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995785 - Disclosure - Marketable Securities - Schedule of Amortized Cost and Estimated Fair Value of Available-for-sale Debt Securities by Contractual Maturity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995805 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment, Net (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995815 - Disclosure - Property and Equipment, Net - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995825 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Goodwill and Intangible Assets Net (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995835 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Goodwill and Intangible Assets Net (Details) (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
995845 - Disclosure - Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995855 - Disclosure - Fair Value Measurements - Schedule of Fair Value of Assets and Liabilities Valued on Recurring Basis (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995865 - Disclosure - Fair Value Measurements - Summary of Changes to Level 3 Fair Value Measurements (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995875 - Disclosure - Fair Value Measurements - Significant Assumptions Used in Valuing the Warrant Liabilities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995885 - Disclosure - Fair Value Measurements - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995895 - Disclosure - Related Party Transactions - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995905 - Disclosure - Shareholders' Equity - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995915 - Disclosure - Shareholders' Equity - Summary of Common Stock Warrants Outstanding (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995925 - Disclosure - Stock-Based Awards - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995935 - Disclosure - Stock-Based Awards - Schedule of Share-based Compensation Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995945 - Disclosure - Stock-Based Awards - Schedule of Stock Based Compensation Expense (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995955 - Disclosure - Stock-Based Awards - Schedule of Calculations of Basic and Diluted Earnings Per Share (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995965 - Disclosure - Stock-Based Awards - Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995975 - Disclosure - Income Taxes - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995985 - Disclosure - Commitments and Contingencies - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995995 - Disclosure - Commitments and Contingencies - Schedule of Supplemental Cash Flow Information Related to Leases (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996005 - Disclosure - Commitments and Contingencies - Schedule of Supplemental Balance Sheet Information Related to Leases (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996015 - Disclosure - Commitments and Contingencies - Schedule of Supplemental Balance Sheet Information Related to Leases (Details) 2
link:presentationLink
link:calculationLink
link:definitionLink
996025 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Commitments (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996035 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Commitments (Details) 2
link:presentationLink
link:calculationLink
link:definitionLink
Weighted Average Grant Date Fair Value Per Share, RSUs Vested
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Weighted Average Exercise Price of Options Outstanding, Options expired/forfeited/cancelled
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
H.C. Wainwright & Co., LLC [Member]
H.C. Wainwright & Co., LLC.
Total
Total finance lease liabilities
Finance Lease, Liability
Entity Incorporation, State or Country Code
Finance Lease, Liability, to be Paid, Year Four
2029
Preferred stock, shares issued
Preferred Stock, Shares Issued
Statement of Financial Position Location, Balance [Domain]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
Balance - beginning of the year
Balance - end of the period
Estimated fair value, In one year or less
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One
Plan Name [Axis]
Equity [Abstract]
Entity Current Reporting Status
Proceeds from Warrant Exercises
Proceeds from exercise of warrants
Gross proceeds from exercise of warrants
Warrants Under Registered Direct Financing [Member]
Warrants under registered direct financing.
OPERATING EXPENSES:
Operating Expenses [Abstract]
Fair Value, Inputs, Level 2 [Member]
Commitments and Contingencies
Commitments and Contingencies Disclosure [Text Block]
Common stock, shares authorized
Common Stock, Shares Authorized
Product and Service [Axis]
Royalties, License and Other Revenues [Member]
Royalties, License and Other Revenues [Member]
Royalties, license and other revenues.
Fair Value by Liability Class [Domain]
Document Fiscal Period Focus
Total lease payments
Total lease payments
Finance Lease, Liability, to be Paid
Accounting Standards Update 2023-09 [Member]
ASU 2023-09 [Member]
Revenue from Contract with Customer [Abstract]
Entity Shell Company
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances
Issued
Cash and cash equivalents
Cash and Cash Equivalents, at Carrying Value, Total
Cash and Cash Equivalent
Included within cash and cash equivalents
Included within cash and cash equivalents
Research and Development Arrangement, Contract to Perform for Others, Type [Axis]
License Agreement [Member]
License Agreement [Member]
Common stock, shares issued
Common Stock, Shares, Issued
Asset Class [Domain]
Statement [Table]
Percentage Of Management Fee Of Aggregate Gross Proceeds
Percentage of management fee of aggregate gross proceeds.
Percentage of management fee of aggregate gross proceeds
Restricted Cash, Noncurrent
Restricted cash included in deposits and other long-term assets (see Note 13 (Commitments and Contingencies))
Operating leases
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Number Of Clinical Trials
Number of clinical trials.
Number of clinical trials
Weighted average grant-date fair value per share of options granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Combined purchase price of common stock and warrants
Combined Purchase Price Of Common Stock And Warrants
Combined purchase price of common stock and warrants.
Statement [Line Items]
Warrants [Member]
Warrant [Member]
Entity Filer Category
Warrants And Rights Expiry Date
Warrants and rights expiry date.
Warrants and rights expiry date
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
Liabilities and Equity
Payables and Accruals [Abstract]
Purchases of marketable debt securities
Payments to Acquire Marketable Securities
Weighted Average Exercise Price of Options exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Deposits and Other Long-Term Assets [Member]
Deposits and Other Long-Term Assets [Member]
Deposits and Other Long-Term Assets [Member]
Long-Lived Tangible Asset [Axis]
Finance Lease, Liability, to be Paid, Year Three
2028
Prepaid Expenses and Other Current Assets [Member]
Prepaid Expenses and Other Current Assets [Member]
Percentage Of Placement Agent Fee
Percentage Of placement agent fee
Percentage Of placement agent fee.
Royalties, license and other revenues.
Royalties, license and other revenues
Royalties, License and Other Revenues
Goodwill
Goodwill
Share-Based Payment Arrangement, Option [Member]
Derivative Liability, Measurement Input
Measurement input
NONCURRENT ASSETS
Assets, Noncurrent [Abstract]
Shares issued upon vesting of restricted stock units, net of shares retired to pay employees' taxes
Shares issued upon vesting of restricted stock units, net of shares retired to pay employees' taxes
Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation
Significant Accounting Policies [Text Block]
Summary of Significant Accounting Policies
Property, Plant and Equipment [Line Items]
Upfront and Royalty payment
Upfront And Royalty Payment Percentage
Upfront and royalty payment percentage
Measurement Input, Risk Free Interest Rate [Member]
Risk-Free Interest Rate [Member]
Vesting [Domain]
Lessee operating lease renewal term description
Lessee Operating Leases Option To Extend
Lessee operating leases option to extend.
Number of Options Outstanding, Options granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Disaggregation of Revenue [Table]
Deposits and other long-term assets
Deposits And Other Longterm Assets Non Current
Deposits and other longterm assets non current.
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Schedule of Calculations of Basic and Diluted Earnings Per Share
Schedule of Amortized Cost and Estimated Fair Value of Available-for-sale Debt Securities by Contractual Maturity
Investments Classified by Contractual Maturity Date [Table Text Block]
Basic net loss per share
Earnings Per Share, Basic, Total
Earnings Per Share, Basic
Basic
Schedule of Disaggregated Revenues
Disaggregation of Revenue [Table Text Block]
MilestonePaymentReceived
Milestone payment received.
Milestone payment received
Sublicensing fee percentage
Sublicensing Fee Percentage.
Accretion of income on marketable debt securities
Accretion of income on marketable debt securities
AccretionOfIncomeOnMarketableDebtSecurities
Schedule of Share-based Compensation Activity
Schedule of Share-Based Compensation, Employee Stock Purchase Plan, Activity [Table Text Block]
Royalty payment percentage
Royalty Payment Percentage.
Comprehensive loss foreign currency translation adjustments, net of tax
Foreign currency translation gain
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total
Foreign currency translation adjustment, net of tax
Number of Options Outstanding, Beginning balance
Number of Options Outstanding, Ending balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
ITI Collaboration Agreement [Member]
ITI Collaboration Agreement [Member]
Interest income, net
Interest Income (Expense), Nonoperating
Total current liabilities
Liabilities, Current
Accounts receivable
Increase (Decrease) in Accounts Receivable
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]
Adjustments to reconcile net loss attributable to Lineage Cell Therapeutics, Inc. to net cash used in operating activities:
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Summary of Changes to Level 3 Fair Value Measurement
Maturities of marketable debt securities
Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale
Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale, Total
Parent Company [Member]
Operating Lease [Member]
Operating Lease [Member]
Accounting Standards Update [Axis]
Es CellInternational Pte Ltd [Member]
Es CellInternational Pte Ltd [Member]
ES Cell International Pte. Ltd. ("ESI") [Member]
Entity Small Business
Accumulated deficit
Accumulated deficit
Retained Earnings (Accumulated Deficit), Total
Retained Earnings (Accumulated Deficit)
Sale of Stock, Price Per Share
Offering price
Alameda Lease [Member]
Alameda Lease [Member]
Total intrinsic value of options exercised
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payment and Postretirement Benefit [Table]
AccountingStandardUpdate20140-9Member
Accounting Standard Update2014-09 [Member]
Accounting Standard Update2014-09 [Member]
Warrants and Rights Outstanding, Measurement Input
Expected dividend yield
Stock-Based Awards
Schedule of Share-based Compensation Activity
Share-Based Payment Arrangement [Text Block]
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Lease Contractual Term [Axis]
Weighted Average Number of Shares Outstanding, Diluted, Adjustment
Weighted Average Number of Shares Outstanding, Diluted, Adjustment, Total
Add: Dilutive effect of warrants
Deferred revenues - end of the period
Total transaction price
Contract with Customer, Liability, Total
Contract with Customer, Liability
Transaction price
Deferred revenues - beginning of the year
Lessee, Lease, Description [Line Items]
Amendment
Amendment Flag
Product and Service [Domain]
Loss Contingencies [Line Items]
Class of Warrant or Right, Date from which Warrants or Rights Exercisable
Date of warrants exercisable
Class of warrant or right, number of securities called by warrants or rights
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Class of warrant or right, number
Chief Executive Officer [Member]
Cash received under Roche Agreement
Cash received under Roche agreement.
Cash received under agreement
LIABILITIES AND SHAREHOLDERS' EQUITY
Liabilities and Equity [Abstract]
Entity Address, Postal Zip Code
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Net cash used in operating activities
Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description
Common Shares
Common Stock [Member]
Accounting Standards Update and Change in Accounting Principle [Table]
Weighted Average Exercise Price of Options Outstanding, Options granted
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Lessee, Operating Lease, Liability, to be Paid, Year Three
2028
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total
Accumulated depreciation and amortization
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Right-of-use assets - Finance Lease [Member]
Finance Lease, Right Of Use Asset, Before Accumulated Amortization [Member]
Finance lease, right of use asset, before accumulated amortization.
Other current liabilities
Other finance lease liabilities current.
OtherFinanceLeaseLiabilitiesCurrent
Research and Development Arrangement, Contract to Perform for Others, Type [Domain]
Royalty Contracts [Member]
Royalty Contracts [Member]
Entity Address, Address Line One
Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]
Schedule of Weighted Average Assumptions to Calculate Fair Value of Stock Options
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Marketable Securities [Table]
Fair Value Hierarchy and NAV [Axis]
NET LOSS PER COMMON SHARE ATTRIBUTABLE TO LINEAGE:
Earnings Per Share [Abstract]
Net loss per common share attributable to Lineage:
SUPPLEMENTAL DISCLOSURES
Supplemental Cash Flow Information [Abstract]
Israel Innovation Authority [Member]
Israel Innovation Authority [Member]
Goodwill and Intangible Assets, Net
Goodwill and Intangible Assets Disclosure [Text Block]
Finance leases, Right-of-use assets
Finance Lease, Right-of-Use Asset, before Accumulated Amortization
Statement of Financial Position Location, Balance [Axis]
Right-of-use assets, net
Operating Lease, Right-of-Use Asset
Operating lease right-of-use assets
Total
Less imputed interest
Finance Lease, Liability, Undiscounted Excess Amount
Net Income (Loss) Attributable to Noncontrolling Interest, Total
Net Income (Loss) Attributable to Noncontrolling Interest
Net (income) loss attributable to noncontrolling interest
Net income (loss) attributable to noncontrolling interest
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax, Total
Unrealized loss on marketable debt securities
Document Type
Document Type
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Lease commencement date
Leases Commencement Date
Lease commencement date.
Ownership percentage
Ownership percentage by parent
Subsidiary, Ownership Percentage, Parent
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Issued
Class of warrant or right exercise price of warrants or rights issued.
Weighted Average Exercise Price, Warrants issued
Base rent increase rate
This refer to base rent increase rate per year as per lease agreement.
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
CIK
Entity Central Index Key
Summary of Available for Sale Debt Securities
Debt Securities, Available-for-Sale [Table Text Block]
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH
Change in right-of-use assets and liabilities.
Change in right-of-use assets and liabilities
Subsequent Event Type [Domain]
Change in fair value of warrant liability
Fair value of warrant liabilities
Change in fair value of warrant liability
Less: Change in fair value of warrant liability
Less: Change in fair value of warrant liability
Antidilutive securities excluded from computation of earnings per share, amount
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Cell Cure Warrants [Member]
Cell Cure Warrants [Member]
Accounting Standards Update 2025-05 [Member]
Accounting Standards Update 2025-05.
ASU 2025-05 [Member]
Accounting Standards Update [Domain]
Class Of Warrant Or Right Exercised
Class of warrant or right exercised.
Warrants exercised
Warrants exercised
Security deposit
Security Deposit
RSUs Vest On or Prior to March 9, 2023 [Member]
Share-Based Payment Arrangement, Tranche One [Member]
First tranche [Member]
Weighted Average Remaining Contractual Team (Years),Options Outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Amortized cost
Debt Securities, Available-for-Sale, Amortized Cost
Amortized cost, Total available-for-sale debt securities
Amortized Cost
Lineage's available-for-sale debt securities
Debt Securities, Available-for-Sale
Estimated fair value, Total available-for-sale debt securities
Fair Value
February 2024 Registered Direct Offering
February Twenty Twenty Four Registered Direct Offering [Member]
February twenty twenty four registered direct offering.
Shares issued upon exercise of stock options, shares
Number of Options Outstanding, Options exercised
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Thousand Twenty Atlantic Premises [Member]
Thousand Twenty Atlantic Premises [Member]
ATM Sales Agreement [Member]
ATM Sales Agreement [Member]
ATM Sales Agreement.
Marketable Securities
Marketable Securities, Total
Marketable debt securities
Included within marketable securities
Accrued liabilities
Accrued Liabilities, Current, Total
Accrued Liabilities, Current
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Ownership [Domain]
Current Fiscal Year End Date
Document Quarterly Report
Entity Address, State or Province
Number of RSUs Outstanding, Ending balance
Number of RSUs Outstanding, Beginning balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Sublicensing fee
Sublicensing Fee
Sublicensing Fee
Common Share Warrant Liabilities [Member]
Common share warrant liabilities.
Warrant Liabilities [Member]
Preferred stock, shares outstanding
Preferred Stock, Shares Outstanding, Ending Balance
Preferred Stock, Shares Outstanding, Beginning Balance
Preferred Stock, Shares Outstanding
COMPREHENSIVE LOSS ATTRIBUTABLE TO LINEAGE COMMON SHAREHOLDERS
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax
Unrealized Gains
Industrial Microbes, Inc [Member]
Industrial Microbes, Inc [Member]
Marketable debt securities
Marketable securities
Marketable Securities, Current
Noncontrolling deficit
Noncontrolling deficit
Equity, Attributable to Noncontrolling Interest, Ending Balance
Equity, Attributable to Noncontrolling Interest, Beginning Balance
Equity, Attributable to Noncontrolling Interest, Total
Equity, Attributable to Noncontrolling Interest
Expected recognized as revenue by 2027
Expected Recognized As Revenue By 2027
Expected recognized as revenue by 2027.
Shares issued upon exercise of stock options
Stock Issued During Period, Value, Stock Options Exercised
January 2018 Lease [Member]
January 2018 Lease [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Other comprehensive loss:
Deferred Income Tax Assets, Net
Deferred tax asset, net
Subsequent Event
Subsequent Event [Member]
Equity securities available for sale
Amount reserved for future issuance
Common Stock Capital Value Reserved For Future Issuance
Common stock capital value reserved for future issuance.
Current deferred revenue
Deferred Revenue, Current
Deferred Revenue, Current, Total
Deferred revenues, current portion
Property, Plant and Equipment [Abstract]
Increase in shares authorized for issuance
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized
Expected Term [Member]
Measurement Input, Expected Term [Member]
Accounts Receivable Net Current Excludes Scope Of ASU 2014 -09
Accounts receivable net current excludes scope of ASU 2014 -09.
Accounts receivable, net - beginning of the year
Accounts receivable, net - end of the period
Antidilutive Securities [Axis]
Subsidiary or Equity Method Investee [Line Items]
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Valuation Techniques [Table Text Block]
Summary of Significant Assumptions used in Valuing Warrant Liabilities
Aggregate Intrinsic Value, Options vested and expected to vest
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
Schedule of Stock Based Compensation Expense
Share-Based Payment Arrangement, Cost by Plan [Table Text Block]
AOCI Attributable to Parent [Member]
Accumulated Other Comprehensive Income / (Loss) [Member]
Finite-Lived Intangible Assets, Major Class Name [Domain]
Cash and Cash Equivalents [Domain]
Preferred Stock, Value, Issued
Preferred shares, no par value, 2,000 shares authorized; none issued and outstanding as of December 31, 2025 and 2024
Preferred shares, no par value, 2,000 shares authorized; none issued and outstanding as of March 31, 2026 and December 31, 2025
Maximum milestone payments to be received upon performance conditions
Maximum milestone payments to be received upon performance conditions.
Minimum [Member]
Weighted average grant-date fair value per share of RSUs granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Financial Instrument [Axis]
CURRENT ASSETS
Assets, Current [Abstract]
Marketable Equity Securities [Member]
Marketable Equity Securities [Member]
Fair Value, Inputs, Level 3 [Member]
Finance leases [Member]
Financing Leases [Member]
Financing Leases [Member]
Schedule of Fair Value of Assets and Liabilities Valued on Recurring Basis
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
CURRENT LIABILITIES
Liabilities, Current [Abstract]
CASH, CASH EQUIVALENTS AND RESTRICTED CASH:
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation [Abstract]
Related Party Transactions [Abstract]
Balance, shares
Balance, shares
Shares, Outstanding
Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]
Schedule of Amortized cost and Estimated fair Value
Base rent and construction allowance per month
Base rent and construction allowance per month.
Accounts receivables amounted
Accounts Receivable, after Allowance for Credit Loss, Current
Accounts Receivable, after Allowance for Credit Loss, Current, Total
Accounts receivable, net - end of the period
Accounts receivable, net - beginning of the period
Accounts receivable
Commitments and Contingencies
Commitments and contingencies (Note 13)
Weighted Average Grant Date Fair Value Per Share, Ending balance
Weighted Average Grant Date Fair Value Per Share, Beginning balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
General and Administrative Expense [Member]
Indefinite-Lived Intangible Assets [Line Items]
Total operating lease liabilities
Total operating lease liabilities
Operating Lease, Liability
Total
Number Of Subject In Phase 12 A
Number of subject in phase 12 A
Number of subject in Phase 1/2a
Common stock, no par value
Common Stock, No Par Value
Finance Lease, Liability, Current
Finance leases, Right-of-use lease liabilities, current
Finance lease liabilities, current portion
Lessee, Lease, Description [Table]
Weighted average discount rate
Finance Lease, Weighted Average Discount Rate, Percent
LONG-TERM LIABILITIES
Liabilities, Noncurrent [Abstract]
Finance leases, Accumulated amortization
Finance Lease, Right-of-Use Asset, Accumulated Amortization
Property and equipment expenditures in accounts payable
Capital Expenditures Incurred but Not yet Paid
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Expired
Class of warrant or right exercise price of warrants or rights expired.
Weighted Average Exercise Price, Warrants expired/forfeited/cancelled
NET LOSS
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
NET LOSS
Net income (loss)
Lease Contractual Term [Domain]
Loss Contingencies [Table]
Weighted Average Number of Shares Outstanding, Basic, Total
Weighted Average Number of Shares Outstanding, Basic
Basic
Basic weighted-average common shares used to compute net loss per common share
Employees [Member]
Employees [Member]
Direct Financing [Member]
Direct Financing .
Direct Financing [Member]
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Clinical development cost
Clinical Development Cost
Clinical development cost.
Aggregate Intrinsic Value, Options exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
Segment Reporting, Expense Information Used by CODM, Description
Base monthly rent
Base rent
Refers to the base monthly rent as per lease agreement.
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Long-Lived Tangible Asset [Domain]
2021 Equity Incentive Plan [Member]
2021 Equity Incentive Plan [Member]
2021 Equity Incentive Plan [Member] [Default Label]
Field of business description
Field of business description.
Related Party Transactions
Related Party Transactions Disclosure [Text Block]
Lineage's shareholders' equity
Equity, Attributable to Parent, Ending Balance
Equity, Attributable to Parent, Beginning Balance
Equity, Attributable to Parent
Statement of Stockholders' Equity [Abstract]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
RSUs Vest On or Prior to Each of Second and Third anniversaries of Such Date [Member]
Share-Based Payment Arrangement, Tranche Two [Member]
January 2025 Closing [Member]
Collaborative Arrangement [Member]
Maximum percentage of milestone payments
Maximum Percentage of Milestone Payments
Maximum Percentage of Milestone Payments
Leasehold Improvements [Member]
Gain (Loss), Foreign Currency Transaction, before Tax
Gain (Loss), Foreign Currency Transaction, before Tax, Total
Foreign currency transaction gain (loss), net
Foreign currency transaction gain (loss), net
Entity Address, Address Line Two
Derivative Liabilities Term
Derivative liabilities term.
Expected term
Fair Value Measurements
Fair Value Disclosures [Text Block]
Significant Accounting Policies [Policy Text Block]
Significant accounting policies.
Significant Accounting Policies
Noncontrolling Interest [Member]
Noncontrolling Deficit [Member]
SUPPLEMENTAL SCHEDULE OF NON-CASH FINANCING AND INVESTINGACTIVITIES:
Noncash Investing and Financing Items [Abstract]
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]
Warrant Liabilities [Member]
Warrant liabilities.
In Process Research and Development [Member]
Plan Name [Domain]
All Entities
Entity [Domain]
Weighted Average Exercise Price of Options exercisable and expected to vest
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price
Finance Lease, Liability, to be Paid, Year One
2026
Financing Costs In Accounts Payable And Accrued Liabilities
financing costs in accounts payable and accrued liabilities
Financing costs in accounts payable and accrued liabilities
Roche Agreement [Member]
Roche Agreement [Member]
Class of Warrant or Right, Outstanding
Beginning balance
Ending balance
Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]
2012 Equity Incentive Plan and 2018 Inducement Option [Member]
Two Thousand Twelve Equity Incentive Plan And Two Thousand Eighteen Inducement Option [Member]
Two thousand twelve equity incentive plan and two thousand eighteen inducement option.
Entity Address, City or Town
Weighted average price per share
Weighted Average Price Per Share
Weighted average price per share.
Number of Reportable Segments
Number of reportable segments
Security Exchange Name
Intangible assets
Fair value of intangible assets
Indefinite-Lived Intangible Assets (Excluding Goodwill), Ending Balance
Indefinite-Lived Intangible Assets (Excluding Goodwill), Beginning Balance
Indefinite-Lived Intangible Assets (Excluding Goodwill), Total
Loss on impairment of intangible asset
Property and equipment, gross
Property, Plant and Equipment, Gross, Ending Balance
Property, Plant and Equipment, Gross, Beginning Balance
Property, Plant and Equipment, Gross, Total
Property, Plant and Equipment, Gross
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
LOSS BEFORE INCOME TAXES
LOSS BEFORE INCOME TAXES
LOSS BEFORE INCOME TAXES
NET LOSS
Cell Cure Neurosciences Ltd [Member]
Cell Cure Neurosciences Ltd [Member]
Cell Cure Neurosciences Ltd. ("CCN") [Member]
Number of Options Vested and Expected to Vest
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Stock Issued During Period Shares Exercise Of Warrants
Stock issued during period shares exercise of warrants.
Shares issued upon exercise of warrants, shares
Measurement Input Type [Domain]
Antidilutive Securities, Name [Domain]
Cell Cure Neurosciences Lease [Member]
Cell cure neurosciences lease.
CCN Leases [Member]
Property Management Fee, Percent Fee
Perentage of management fee
At end of the period
At beginning of the period
Total cash, cash equivalents, and restricted cash
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Cash paid for interest
Interest Paid, Excluding Capitalized Interest, Operating Activity
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Statistical Measurement [Domain]
Financing related fees.
Financing related fees
Exercise price per share
Class of Warrant or Right, Exercise Price of Warrants or Rights
Weighted Average Exercise Price, Begining balance
Weighted Average Exercise Price, Ending balance
Total current assets
Assets, Current
Stock Issued During Period Value Exercise Of Warrants
Stock issued during period value exercise of warrants.
Shares issued upon exercise of warrants
Total stock-based compensation expense
Share-Based Payment Arrangement, Expense
Period End Date
Document Period End Date
Title and Position [Axis]
Fair Value Hierarchy and NAV [Domain]
Payment of financed insurance premium
Payment of Financed Insurance Premium
Payment of financed insurance premium.
Other Collaborative Revenue [Member]
Other collaborative revenue.
Other Collaborative Revenue [Member]
Number of Options exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
2021 Equity Incentive Plan [Member]
2021 Equity Incentive Plan [Member]
2021 Equity Incentive Plan [Member]
Net Rentable Area
Rentable area
Statement of Financial Position [Abstract]
Restricted Stock Units [Member]
Restricted Stock Units (RSUs) [Member]
Restricted Stock Units (RSUs) [Member]
1010 Atlantic Premises [Member]
Thousand Ten Atlantic Premises [Member]
Antidilutive Security, Excluded EPS Calculation [Table]
Vesting [Axis]
Reconciliation Of Cash Cash Equivalents And Restricted Cash End Of Period [Abstract]
Reconciliation of cash cash equivalents and restricted cash end of period.
RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD:
Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]
TOTAL LIABILITIES
Liabilities
Financial Instruments [Domain]
Increase (Decrease) in Deferred Revenue
Deferred revenue
Lessee, Operating Lease, Liability, to be Paid, Year Two
Rent for remaining twelve months
2027
Deposit assets
Restricted cash
Restricted Cash
Restricted Cash, Total
Amortization expense for right-of-use finance lease assets
Finance Lease, Right-of-Use Asset, Amortization
Indefinite-Lived Intangible Assets, Major Class Name [Domain]
Prior Sales Agreement [Member]
Prior Sales Agreement [Member]
Prior sales agreement.
Intangible assets subject to amortization
Finite-Lived Intangible Assets, Gross
Cash and Cash Equivalent [Table]
Weighted Average Number of Shares Outstanding, Diluted
Diluted
Diluted weighted-average common shares used to compute net loss per common share
Entity File Number
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax
Unrealized gain (loss) on marketable debt securities
Cover
Cover [Abstract]
First Tranche [Member]
First tranche.
Measurement Input Type [Axis]
Warrants expired/forfeited/cancelled
Class Of Warrant Or Right Expired
Class of warrant or right expired.
Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total
Increase (Decrease) in Accounts Payable and Accrued Liabilities
Accounts payable and accrued liabilities
Prepaid expenses and other current assets
Prepaid Expense and Other Assets, Current
Number of restricted stock units, forfeited
Number of RSUs Outstanding, RSUs forfeited
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
US Treasury Securities [Member]
Number of shares authorized for issuance
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized
Number of Operating Segments
Number of operating segments
Sale of Stock [Domain]
General and Administrative Expense
General and administrative
General and Administrative Expense, Total
Equipment Furniture And Fixtures Member
Equipment Furniture And Fixtures [Member]
Revenue recognized included in deferred revenue
Revenue Recognized From Deferred Revenue At Beginning Of Period
Revenue recognized from deferred revenue at beginning of period.
Total revenues under collaborative agreements
Revenue from Contract with Customer, Including Assessed Tax
Collaboration revenues
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Total
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
Number of Options Outstanding, Options expired/forfeited/cancelled
Finite-Lived Intangible Assets, Net
Finite-Lived Intangible Assets, Net, Ending Balance
Finite-Lived Intangible Assets, Net, Beginning Balance
Total intangible assets
Derivative Warrant Liability Reclassified To Equity Upon Exercise Of Warrants
Derivative warrant liability reclassified to equity upon exercise of warrants.
Derivative warrant liability reclassified to equity on exercise of warrants
Operating Lease, Expense
Operating lease expense
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Weighted Average Exercise Price of Options vested and expected to vest
Property, plant and equipment, useful life
Property, Plant and Equipment, Useful Life
New Accounting Pronouncements, Policy [Policy Text Block]
Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted
Schedule of Future Minimum Lease Commitments
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercised
Class of warrant or right exercise price of warrants or rights exercised.
Weighted Average Exercise Price, Warrants exercised
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Gain (Loss) on Disposition of Assets
Gain (Loss) on Disposition of Assets, Total
Loss on disposal of assets
Loss on disposal of assets
Weighted Average Price Per Share Issuance Of Common Stock
Weighted average price per share issuance of common stock.
Weighted average price per share issuance of common stock
Ownership [Axis]
Foreign Currency Remeasurement, Gain (Loss), Before Tax
Foreign currency remeasurement, gain (loss), before tax.
Foreign currency remeasurement
Upfront license fees [Member]
Upfront License Fees [Member]
Upfront License Fees [Member]
Number of subject in Phase 1
Number Of Subject In Phase 1
Number Of Subject In Phase 1
Collaboration Revenues [Member]
Collaboration Revenues Member
Collaboration Revenues [Member]
Common Stock, Shares, Outstanding, Beginning Balance
Common stock, shares outstanding
Common Stock, Shares, Outstanding, Ending Balance
Common Stock, Shares, Outstanding
Operating Lease, Liability, Current
Right-of-use lease liabilities, current
Operating lease liabilities, current portion
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Schedule of Lineage's Ownership of Outstanding Shares of its Subsidiaries
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table Text Block]
Remaining performance obligations
Revenue, Remaining Performance Obligation, Amount
Document Transition Report
Research and development
Research and Development Expense, Total
Research and Development Expense
Research collaboration costs
COMPREHENSIVE LOSS
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest
Statement of Cash Flows [Abstract]
Stock Issued During Period, Value, New Issues
Shares issued through registered direct financings
Shareholders' Equity
Equity [Text Block]
Finite-Lived Intangible Assets [Line Items]
Expected dividend yield [Member]
Measurement Input, Expected Dividend Rate [Member]
Net loss attributable to Lineage
NET LOSS ATTRIBUTABLE TO LINEAGE
Aggregate Intrinsic Value, Options Outstanding
Aggregate Intrinsic Value, Options Outstanding, Ending Balance
Aggregate Intrinsic Value, Options Outstanding, Beginning balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
B. Riley Securities, Inc. [Member]
B. Riley Securities, Inc. [Member]
B. Riley Securities, Inc. [Member]
Finance leases, Right-of-use lease liabilities, current
Finance Lease Liability Excluding Other Liabilities Current
Finance lease liability excluding other liabilities current.
Accounting Changes and Error Corrections [Abstract]
Equity Securities, FV-NI, Unrealized Gain (Loss)
Unrealized loss recognized on marketable equity securities held at end of period, net
Intangible Assets, Net (Excluding Goodwill)
Intangible assets, net
Intangible assets, net
Operating cash flows from operating leases
Operating Lease, Payments
Aggregate Intrinsic Value, Options exercisable and expected to vest
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value
ASSETS
Assets [Abstract]
Prepaid expenses and other current assets
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) In Financed Insurance Premium
Increase (decrease) in financed insurance premium.
Financed insurance premium
Document Fiscal Year Focus
Right-of-use assets - Operating Lease [Member]
Operating Lease, Right Of Use Asset, Before Accumulated Amortization [Member]
Operating lease, right of use asset, before accumulated amortization.
Upfront payment
Upfront payment.
Aggregate cash fee percentage
Aggregate Cash Fee Percentage
Aggregate cash fee percentage.
CASH FLOWS FROM INVESTING ACTIVITIES:
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]
Accounts payable
Accounts Payable, Current, Total
Accounts Payable, Current
Fair value of the options vested
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value
Land subject to ground leases
Land Subject to Ground Leases
Research and Development Expense [Member]
Marketable Equity Securities
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]
Marketable Securities
Schedule of Contract with Customer Contract Liability and Receivable
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]
Deferred revenues - end of the period
Deferred revenues - beginning of the period
Deferred revenue
Deferred Revenue, Total
Deferred Revenue
Deferred revenues
Equity Securities, FV-NI, Gain (Loss)
Loss on marketable equity securities, net
(Gain) loss on marketable equity securities, net
Gain (loss) on marketable equity securities, net
Subsidiary or Equity Method Investee, Sale of Stock [Table]
Stock-based compensation
Adjustments To Common Stock Share Based Compensation Requisite Service Period Recognition Value
Adjustments to common stock share based compensation requisite service period recognition value.
Proceeds from employee options exercised
Proceeds from Stock Options Exercised
Fair Value Disclosures [Abstract]
Commitments and Contingencies Disclosure [Abstract]
Lessee, Operating Lease, Liability, to be Paid, Year One
Rent for first twelve months
2026
Intangible Asset, Indefinite-Lived [Table]
Sublease term
Sublease term.
Net Income (Loss) Available to Common Stockholders, Basic
Net loss per common share attributable to Lineage
Net loss attributable to Lineage - basic EPS
Contract with Customer, Asset, after Allowance for Credit Loss, Current
Contract with Customer, Asset, after Allowance for Credit Loss, Current, Total
Contract assets
Share-Based Payment Arrangement [Abstract]
Hadasit Medical Research Services and Development Ltd [Member]
Hadasit Medical Research Services And Development Ltd [Member]
Assets
Assets, Fair Value Disclosure, Total
Assets, Fair Value Disclosure
Sale of Stock [Axis]
At the Market [Member]
At the market .
ATM [Member]
Sublease agreement option to extend
Lessee, Operating Sublease, Option to Extend
Total revenues
Total revenues
Revenues
Revenues
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Net cash (used in) provided by investing activities
Fair Value of Warrant Liability Recognized upon Issuance in Registered Direct Financing
Fair value of warrant liability recognized upon issuance in registered direct financing.
Fair value of warrant liability recognized upon issuance in registered direct financing
Weighted average remaining lease term
Finance Lease, Weighted Average Remaining Lease Term
Title of 12(b) Security
Weighted Average Grant Date Fair Value Per Share, RSUs forfeited
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Money Market Funds [Member]
Income Taxes
Income Tax Disclosure [Text Block]
Event Based Milestones and Other Collaborative Revenue [Member]
Event Based Milestones And Other Collaborative Revenue [Member]
Event-based milestones and other collaborative revenue.
Gross Proceeds from Sale of Common Stock
Gross Proceeds from Sale of Common Stock
Aggregate gross proceeds from issuance of common stock
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Gross proceeds from issuance of common stock
Gross Proceeds from Issuance of Common Stock
Gross proceeds from issuance of common stock.
Patents [Member]
Consolidated Entities [Axis]
Finance leases, Right-of-use assets, net
Finance leases, Right-of-use assets, net
Finance Lease, Right-of-Use Asset, after Accumulated Amortization
Legal Entity:
Legal Entity [Axis]
Changes in operating assets and liabilities:
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]
Schedule of Property and Equipment, Net
Property, Plant and Equipment [Table Text Block]
Weighted Average Exercise Price of Options Outstanding, Beginning balance
Weighted Average Exercise Price of Options Outstanding, Ending balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Income Tax Disclosure [Abstract]
Fair Value, Recurring and Nonrecurring [Table]
Statement of Income Location, Balance [Axis]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Trading Symbol
Intangible Asset, Finite-Lived [Table]
Property and Equipment, Net
Property, Plant and Equipment Disclosure [Text Block]
Amortized cost, In one year or less
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One
Subsequent Event Type [Axis]
Accrued compensation
Employee-related Liabilities, Current, Total
Employee-related Liabilities, Current
CASH FLOWS FROM FINANCING ACTIVITIES:
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]
Accounts Payable and Accrued Liabilities
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
Total lease payments
Total lease payments
Lessee, Operating Lease, Liability, to be Paid
Less imputed interest
Less imputed interest
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Equity Components [Axis]
Weighted Average Remaining Contractual Team (Years), Options exercisable and expected to vest
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term
other income (expenses)
Nonoperating Income (Expense)
Total other income (expenses)
Class Of Warrant Or Right Issued
Class of warrant or right issued.
Warrants issued
Equity Component [Domain]
Asset Class [Axis]
Goodwill and Intangible Assets Disclosure [Abstract]
Deferred Revenue, Noncurrent
Deferred Revenue, Noncurrent, Total
Deferred revenues, net of current portion
Cash and cash equivalents and marketable securities
Cash And Cash Equivalents And MarketableSecurities.
Additional Clinical Development Cost
Additional clinical development cost.
Additional clinical development cost
Shares issued upon vesting of restricted stock units, net of shares retired to pay employees' taxes, shares
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures, Total
Broadwood Partners, L.P [Member]
Broadwood Partners, L.P [Member]
Sales agreement amount
Sales Agreement Amount
Sales agreement amount
Depreciation and amortization expense
Depreciation, Depletion and Amortization, Nonproduction, Total
Depreciation, Depletion and Amortization, Nonproduction
Depreciation and amortization expense
Organization, Basis of Presentation and Liquidity
Organization, Basis of Presentation and Liquidity Disclosure [Text Block]
Organorganization, basis of presentation and liquidity.
Maximum [Member]
Maximum [Member]
2012 and 2018 Equity Incentive Plan
2012 and 2018 Equity Incentive Plan [Member]
2012 and 2018 Equity Incentive Plan [Member]
Liabilities
Liabilities, Fair Value Disclosure, Total
Liabilities, Fair Value Disclosure
Fair value of warrant liabilities
Statistical Measurement [Axis]
Weighted Average Exercise Price of Options, Options exercised
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Accumulated amortization
Finite-Lived Intangible Assets, Accumulated Amortization
Common Stock, Value, Issued
Common shares, no par value, 450,000 shares authorized as of December 31, 2025 and 2024; 230,328 and 220,416 shares issued and outstanding as of December 31, 2025 and 2024, respectively
Common shares, no par value, 450,000 shares authorized as of March 31, 2026 and December 31, 2025; 249,298 and 243,122 shares issued and outstanding as of March 31, 2026 and December 31, 2025 , respectively
Net Income (Loss) Available to Common Stockholders, Diluted
Net loss attributable to Lineage - diluted EPS
Repayment of finance lease liabilities
Financing cash flows from finance leases
Finance Lease, Principal Payments
Payment of finance lease liabilities
Cash and Cash Equivalents [Abstract]
Total shareholders’ equity
Balance
Balance
Equity, Including Portion Attributable to Noncontrolling Interest
Pay costs percentage
Pay costs percentage.
Issuance Costs For Common Stock Warrant Liabilities
Issuance costs for common stock warrant liabilities.
Issuance costs for common stock warrant liabilities
Cash and Cash Equivalents [Line Items]
Marketable Securities [Line Items]
Schedule of Intangible Assets Future Amortization Expenses
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]
Milestone payment
Milestone Payment
Milestone payment.
Upfront payment percentage
Upfront Payment Percentage
Upfront Payment Percentage
Consolidation, Less-than-Wholly-Owned Subsidiary, Parent Ownership Interest, Effect of Change [Table]
Preferred stock, shares authorized
Preferred Stock, Shares Authorized
Royalty Expense
Cost of royalties
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest, Total
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest
Comprehensive (income) loss attributable to noncontrolling interest
Costs and Expenses
Total operating expenses
Finite-Lived Intangible Assets by Major Class [Axis]
Neal Bradsher [Member]
Neal Bradsher [Member]
Common shares received and retired for employee taxes paid
Payment, Tax Withholding, Share-Based Payment Arrangement
Revenue
Revenue from Contract with Customer [Text Block]
Registrant Name
Entity Registrant Name
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax
Unrealized Losses
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]
Other Nonoperating Income (Expense), Total
Other Nonoperating Income (Expense)
Other income (expense), net
Upfont payment received
Upfront payment received
Upfront payment received.
Accounts payable and accrued liabilities
Accounts Payable and Accrued Liabilities, Current
Total
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Number of restricted stock units to be vested
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options to be Vested In Period
Share based compensation arrangement by share based payment award equity instruments other than options to be vested in period.
Consolidated Entities [Domain]
Income Tax Expense (Benefit)
Income Tax Expense (Benefit), Total
Income tax benefit
Income tax benefit
Proceeds from Issuance of Common Stock
Proceeds from issuance of common stock
Proceeds from sale of common shares with warrants under registered direct financing, net of offering costs
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Entity Common Stock, Shares Outstanding
Liability Class [Axis]
Accumulated other comprehensive loss
Accumulated other comprehensive loss
Accumulated Other Comprehensive Income (Loss), Net of Tax, Total
Accumulated Other Comprehensive Income (Loss), Net of Tax
Lineage Lease [Member]
Lineage Lease.
Purchase of equipment
Payments to Acquire Property, Plant, and Equipment, Total
Payments to Acquire Property, Plant, and Equipment
Number of RSUs Outstanding, RSUs granted
Number of RSUs Outstanding, RSUs granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period
Number of restricted stock units, granted
TOTAL ASSETS
Assets
Property, Plant and Equipment [Table]
IPR&D - OPC1 [Member]
IPR&D - OPC1 [Member]
Weighted Average Remaining Contractual Team (Years),Options exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Income Statement [Abstract]
Operating cash flows from finance leases
Finance Lease, Interest Payment on Liability
Office and Laboratory Space, Jerusalem, Israel [Member]
Office and Laboratory Space, Jerusalem, Israel [Member]
Net proceeds
Amount reserved for future issuance
Common Stock Capital Value Maximum Authorized Shares Available For Future Issuance
Common stock capital value maximum authorized shares available for future issuance.
Preferred stock, no par value
Preferred Stock, No Par Value
Deferred tax benefit
Deferred income tax benefit
Deferred Income Tax Expense (Benefit)
Deferred Income Tax Expense (Benefit), Total
Equity Securities, FV-NI, Realized Gain (Loss)
Less: Loss recognized in earnings on marketable equity securities sold
Sale of stock
Sale of Stock, Number of Shares Issued in Transaction
Stock Issued During Period, Shares, New Issues
Shares issued through registered direct financings, shares
Number of RSUs Outstanding, RSUs vested
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Diluted net loss per share
Earnings Per Share, Diluted
Earnings Per Share, Diluted, Total
Diluted
Title and Position [Domain]
Derivative Warrant Liability Reclassified To Share Capital Upon Exercise Of Warrants
Derivative warrant liability reclassified to share capital upon exercise of warrants.
Derivative warrant liability reclassified to equity upon exercise of warrants
Derivative warrant liabilitiy reclassified to equity on exercise of warrants
City Area Code
Schedule of Supplemental Cash Flow Information Related to Leases
Schedule of supplemental cash flow information related to leases [Table Text Block]
Finance leases, Right-of-use lease liabilities, noncurrent
Finance Lease, Liability, Noncurrent
Finance lease liabilities, net of current portion
Schedule of Goodwill and Intangible Assets Net
Schedule of Intangible Assets and Goodwill [Table Text Block]
Cell Cure Leases [Member]
Cell cure leases.
Marketable Debt Securities [Member]
Marketable Debt Securities [Member]
Weighted average remaining lease term
Operating Lease, Weighted Average Remaining Lease Term
Lease expiration date
Lease Expiration Date
Aggregate cap amount
Aggregate Cap Amount.
Total
Property and equipment, net
Property, Plant and Equipment, Net
Property and equipment, net
Finance leases
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability
Number of Options Exercisable and Expected to Vest
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number
Operating Income (Loss)
Loss from operations
Loss from operations
Carlsbad Lease [Member]
Carlsbad Lease [Member]
Schedule of Composition of Lineage's Long-Lived Assets
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]
Retained Earnings [Member]
Accumulated Deficit [Member]
Don M. Bailey [Member]
Don M. Bailey.
Cash and Cash Equivalents [Axis]
Settlement Agreement [Member]
Settlement Agreement [Member]
Total stock-based compensation expense
Share-Based Payment Arrangement, Noncash Expense, Total
Stock-based compensation
Share-Based Payment Arrangement, Noncash Expense
Measurement Input, Price Volatility [Member]
Expected Stock Price Volatility [Member]
Payments for offering costs
Payments of Stock Issuance Costs
Stock issuance costs
Asterias Equity Plan [Member]
Asterias Equity Plan [Member]
Lineage Subleases [Member]
Lineage Subleases.
Weighted average discount rate
Operating Lease, Weighted Average Discount Rate, Percent
Operating Lease, Liability, Noncurrent
Right-of-use lease liabilities, noncurrent
Operating lease liabilities, net of current portion
Fair Value, Inputs, Level 1 [Member]
Net cash provided by financing activities
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Schedule of Supplemental Balance Sheet Information Related to Leases
Lease, Cost [Table Text Block]
Accounting Standards Adoption
Change in Accounting Principle, Accounting Standards Update, Adopted [true false]
Deferred Income Tax Liabilities, Net
Deferred tax liability, net
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
Summary of Common Stock Warrants Outstanding
OTHER INCOME (EXPENSES):
Nonoperating Income (Expense) [Abstract]
Warrant liabilities
Derivative Liability, Noncurrent
Marketable Securities [Table Text Block]
Schedule of Marketable Equity Securities
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share
IPR&D - VAC2 [Member]
IPR&D - VAC2 [Member]
Percentage of commission payable
Refers to a commission payable to the seller as a percentage of gross proceeds from the sale of shares of the entity.
Entity Interactive Data Current
Immunomic Therapeutics Inc [Member]
Immunomic Therapeutics Inc [Member]
Statement of Income Location, Balance [Domain]
Schedule of Fair Value of Marketable Securities
Schedule Of Securities Owned Readily Marketable [Table Text Block]
Securities owned readily marketable.
CASH FLOWS FROM OPERATING ACTIVITIES:
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]
Carlsbad Sub Lease [Member]
Carlsbad Sub Lease [Member]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
Change in fair value of warrant liability recognized in the consolidated statement of operations
Research Collaboration Agreement with William Demant Invest [Member]
Research collaboration agreement with william demant invest.
Research Collaboration Agreement with William Demant Invest [Member]
Entity Tax Identification Number
SHAREHOLDERS' EQUITY
Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]
Revenues [Abstract]
REVENUES:
San Diego Sublease [Member]
San Diego sublease.
Effect of exchange rate changes on cash, cash equivalents and restricted cash
Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Proceeds from sale of common shares with warrants
Proceeds from Issuance or Sale of Equity
Proceeds from Issuance or Sale of Equity, Total
Local Phone Number
Agreements With Hadasit and IIA [Member]
Agreements With Hadasit And I I A [Member]
Agreements With Hadasit And I I A.
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Unrecognized compensation costs
Owned Product Candidate One Clinical Development [Member]
Owned product candidate one clinical development.
OPC1 Clinical Development [Member]
WEIGHTED-AVERAGE COMMON SHARES USED TO COMPUTE NET LOSS PER COMMON SHARE:
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Finance Lease, Liability, to be Paid, Year Two
2027
Accounting Policies [Abstract]
Grants awarded percentage
Grants Awarded Percentage.
Disaggregation of Revenue [Line Items]
Total revenues
Total revenues
Revenue from Contract with Customer, Excluding Assessed Tax
Revenue
Lessee, Operating Lease, Liability, to be Paid, Year Four
2029
Cash and Cash Equivalents [Member]
Cash and Cash Equivalents [Member]
Number of shares available for grant
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant
Weighted average period for recognition
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Schedule of Accounts Payable and Accrued Liabilities
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]
Entity Emerging Growth Company
Weighted Average Remaining Contractual Team (Years), Options vested and expected to vest
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term
Indefinite-Lived Intangible Assets [Axis]